Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Richland Glass is a U.S.-based precision glass manufacturer that supplies custom glass and quartz components, tubing, vials, ampoules, and related assemblies for medical, diagnostic, life science, electronics, and industrial applications. The company appears to operate primarily as an OEM and co-development manufacturing partner rather than as a therapeutics developer. In life sciences, Richland supports analytical instrument OEMs and diagnostic workflows with specialty glass containment and microfluidic sample-handling solutions used in discovery, diagnostics, and laboratory applications. Richland was acquired by Artemis Capital Partners in January 2025 and, in January 2026, merged with McDanel Advanced Materials and now operates as McDanel Glass Solutions while continuing customer support and production continuity. Its capabilities include custom engineering, sample qualification lots, precision glass processing, and FDA Drug Master File support for certain customer programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Richland Glass.